Structural Heart Disease Program

The FDA approves the first artificial heart valve that does not require open heart surgery:

Heart researchers from our center played a key role in the approval of the first artificial heart valve that can replace the aortic heart valve without open-heart surgery.

Read the entire article.

.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .

Less Invasive Treatments for Heart Disease

The field of Structural Heart Disease (SHD) is a rapidly evolving discipline in interventional cardiology that addresses disorders of the heart with minimally invasive methods. Our program actively provides alternatives to open heart surgery to eligible patients in the following areas. Some of these treatments are only available through FDA-approved clinical trials.

• Aortic Stenosis
• Mitral Regurgitation
• Left Atrial Appendage Closure (stroke prevention in the setting of atrial fibrillation)
• Patent Foramen Ovale, Atrial Septal Defect, Ventricular Septal Defect
• Paravalvular Defects

Interventional repair of structural heart defects is expanding at an incredible rate. While many of these therapies are in the investigational phase, numerous trials are ongoing and the excitement is palpable. Some of these technologies may eventually become the standard of care, while others will remain options for patients who are not candidates for heart surgery.

A Leader in Structural Heart Disease Research

The Structural Heart Disease Team is actively involved in these research trials:

• Aortic Stenosis - PARTNER Trial & PARTNER II Trial
• Mitral Regurgitation - REALISM Trial
• Left Atrial Appendage Closure - PREVAIL Trial

• Learn more about our research trials.

Hybrid Catheterization Laboratory/
Operating Room

Intermountain Medical Center's state-of-the-art heart tower includes a hybrid catheterization/operating room with the ability to perform open heart surgery as well as catheter-based procedures guided by fluoroscopy and ultrasound. The hybrid room is an optimal clinical space for interventional cardiologists and cardiovascular surgeons to collaborate and perform less invasive procedures. The space allows our program's team to provide unparalleled comprehensive care to challenging, high-risk patients.